SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-089385
Filing Date
2019-03-28
Accepted
2019-03-28 08:05:33
Documents
8
Period of Report
2019-03-26
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d728511d8k.htm 8-K 23279
2 EX-1.1 d728511dex11.htm EX-1.1 190778
3 EX-5.1 d728511dex51.htm EX-5.1 6627
4 EX-99.1 d728511dex991.htm EX-99.1 11881
5 EX-99.2 d728511dex992.htm EX-99.2 11528
6 GRAPHIC g728511g0327112022447.jpg GRAPHIC 2836
7 GRAPHIC g728511g0327112423883.jpg GRAPHIC 2439
8 GRAPHIC g728511g0327112434398.jpg GRAPHIC 2439
  Complete submission text file 0001193125-19-089385.txt   256278
Mailing Address 333 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 333 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-741-0900
MyoKardia Inc (Filer) CIK: 0001552451 (see all company filings)

IRS No.: 455500552 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37609 | Film No.: 19710014
SIC: 2834 Pharmaceutical Preparations